Article
MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets
14 Feb 2022
Abstract excerpt
Alzheimer's disease (AD) is the most common neurodegenerative disease, with cognitive decline as the primary clinical feature. According to epidemiological statistics, 50 million people worldwide are currently affected by Alzheimer's disease. Although new drugs such as aducanumab have been approved for use in the treatment of AD, none of them have reversed the progression of AD. MicroRNAs (miRNAs) are small...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
